Literature DB >> 906794

Amyotrophic lateral sclerosis in Finland. II: Clinical characteristics.

M Jokelainen.   

Abstract

The clinical characteristics of ALS in Finland were investigated. The study was based on the hospital records of 255 patients. No correlation was found between the disease and other previous illnesses. Muscular weakness was the most frequent complaint of the patients as their first symptom (149/255, i.e. 58 per cent). The duration of the disease was shortest (1.9 years) in male cases with the first symptoms in the bulbar area, and it was longest (3.4 years) in females with a spinal onset of the symptoms. The duration of the disease was in inverse relation to the age when it was contracted. Progressive muscular atrophy with fasciculations was considered the most important clinical sign of ALS. It was most frequently observed in the upper extremities including shoulders. Sensory disturbances were absent, sphincter abnormalities were reported in only three cases, bed sores did not exist, and there were no reports of impotence in the male patients. Two families with two familial cases in each were found, altogether two men and two women. Their disease did not differ from that of the rest of the series. The ALS patients soon became too disabled to work; 56 per cent bacame permanently disabled in less than 1 year's time, and only 9 per cent retained their working capacity for more than 2 years. The average length of stay at hospital was 32 days for ALS and 37 days for MS patients, but the later group was hospitalized 2-3 times more frequently than the former. Gastrostomy or tracheostomy and artificial respiration did not lenghten the lives of the patients.

Entities:  

Mesh:

Year:  1977        PMID: 906794     DOI: 10.1111/j.1600-0404.1977.tb01425.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  14 in total

1.  Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis.

Authors:  P J Massman; J Sims; N Cooke; L J Haverkamp; V Appel; S H Appel
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-11       Impact factor: 10.154

Review 2.  ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration.

Authors:  John M Ravits; Albert R La Spada
Journal:  Neurology       Date:  2009-09-08       Impact factor: 9.910

3.  Preclinical and subclinical events in motor neuron disease.

Authors:  M Swash; D Ingram
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-02       Impact factor: 10.154

Review 4.  Motor neuron disease.

Authors:  P N Leigh; K Ray-Chaudhuri
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-08       Impact factor: 10.154

5.  Amyotrophic lateral sclerosis in the province of Parma, Italy: a clinical and epidemiological study in the period 1960-1980.

Authors:  G Juvarra; L Bettoni; E Bortone; A Garavelli; E Montanari; M Rocca
Journal:  Ital J Neurol Sci       Date:  1983-12

6.  Presenile dementia with motor neuron disease in Japan: clinico-pathological review of 26 cases.

Authors:  Y Mitsuyama
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-09       Impact factor: 10.154

7.  Prognosis and clinical varieties of ALS disease.

Authors:  P Mortara; D Bardelli; M Leone; D Schiffer
Journal:  Ital J Neurol Sci       Date:  1981-08

Review 8.  Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease.

Authors:  Hans Dieter Katzberg; Michael Benatar
Journal:  Cochrane Database Syst Rev       Date:  2011-01-19

9.  Amyotrophic lateral sclerosis with marked neurological asymmetry: clinicopathological study.

Authors:  Y Mochizuki; T Mizutani; T Takasu
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

10.  Comparison of sporadic and familial disease amongst 580 cases of motor neuron disease.

Authors:  T M Li; E Alberman; M Swash
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.